{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:17:34Z","timestamp":1787894254936,"version":"build-2784847793"},"reference-count":34,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Issues Mol. Biol.","CIMB"],"abstract":"<jats:p>Diabetes mellitus is a worldwide metabolic disorder that can be debilitating to many if uncontrolled. Biomarkers, such as hemoglobin A1C and glycated albumin, are central to the effort to control diabetes. These each have their own advantages and disadvantages, and there is much ongoing research into development of improved biomarkers and biomarker measurement methods. Continuous glucose monitoring is also widely used to closely monitor diabetes in patients today. Increasingly, however, there has been research focusing on the use of biomarkers in alternative mediums, such as tear fluid or saliva. This review efficiently summarizes the current biomarkers used clinically today, their advantages and disadvantages, and the biomarkers on the horizon that could advance how diabetes is treated in the future.<\/jats:p>","DOI":"10.3390\/cimb48090866","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:54:42Z","timestamp":1787763282000},"page":"866","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Evaluation of Traditional and Emerging Glycemic Biomarkers in Diabetes"],"prefix":"10.3390","volume":"48","author":[{"given":"Jeremy","family":"Jones","sequence":"first","affiliation":[{"name":"Pittsburgh Research Institute, Sewickley, PA 15143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Frenia","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen C.","family":"Garwood","sequence":"additional","affiliation":[{"name":"Department of Decision and System Sciences, Saint Joseph\u2019s University, Philadelphia, PA 19131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-1226","authenticated-orcid":false,"given":"Kunhong","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, College of Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA"},{"name":"Center for Proteomics & Artificial Intelligence, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15212, USA"},{"name":"Center for Clinical Mass Spectrometry, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne T.","family":"Labriola","sequence":"additional","affiliation":[{"name":"Pittsburgh Research Institute, Sewickley, PA 15143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"BMI-S38440","DOI":"10.4137\/BMI.S38440","article-title":"Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients","volume":"11","author":"Sherwani","year":"2016","journal-title":"Biomark. Insights"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes\u20142023","volume":"46","author":"Elsayed","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial Research Group, Nathan, D.M., Genuth, S., Lachin, J., Cleary, P., Crofford, O., Davis, M., Rand, L., and Siebert, C. (1993). The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N. Engl. J. Med., 329, 977\u2013986.","DOI":"10.1056\/NEJM199309303291401"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1932296819841698","article-title":"Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus","volume":"14","author":"Klonoff","year":"2020","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2337\/dc22-1399","article-title":"The Impact of Carbamylation and Anemia on HbA1c\u2019s Association with Renal Outcomes in Patients with Diabetes and Chronic Kidney Disease","volume":"46","author":"Tang","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Alzahrani, B.A., Salamatullah, H.K., Alsharm, F.S., Baljoon, J.M., Abukhodair, A.O., Ahmed, M.E., Malaikah, H., and Radi, S. (2023). The effect of different types of anemia on HbA1c levels in non-diabetics. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-023-01280-y"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.5888\/pcd18.200365","article-title":"HbA1c Performance in African Descent Populations in the United States with Normal Glucose Tolerance, Prediabetes, or Diabetes: A Scoping Review","volume":"18","author":"Khosla","year":"2021","journal-title":"Prev. Chronic Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of Continuous Glucose Monitoring on Glycemic Control in Adults with Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3949\/ccjm.91a.23090","article-title":"Using continuous glucose monitoring data in daily clinical practice","volume":"91","author":"Martens","year":"2024","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e002573","DOI":"10.1136\/bmjdrc-2021-002573","article-title":"Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: A systematic review","volume":"10","author":"Raj","year":"2022","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1932296819867683","article-title":"Understanding Patient and Provider Perspective on Impact of Professional Continuous Glucose Monitors on Diabetes Control in a Complex Care Population","volume":"13","author":"Raju","year":"2019","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/dom.15920","article-title":"Automating insulin delivery through pump and continuous glucose monitoring connectivity: Maximizing opportunities to improve outcomes","volume":"26","author":"Anandhakrishnan","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e2445316","DOI":"10.1001\/jamanetworkopen.2024.45316","article-title":"Disparities in Continuous Glucose Monitoring Among Patients Receiving Care in Federally Qualified Health Centers","volume":"7","author":"Wallia","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/15209156251403569","article-title":"The Impact of Continuous Glucose Monitoring Use Versus Nonuse on Clinical and Economic Outcomes in Individuals Using Rapid- and Short-Acting Insulin: A Retrospective Analysis","volume":"28","author":"Dennis","year":"2025","journal-title":"Diabetes Technol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2337\/cd16-0008","article-title":"Continuous Glucose Monitoring: A Perspective on Its Past, Present, and Future Applications for Diabetes Management","volume":"35","author":"Mariani","year":"2017","journal-title":"Clin. Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20420188241304459","DOI":"10.1177\/20420188241304459","article-title":"Evaluating the precision and reliability of real-time continuous glucose monitoring systems in ambulatory settings: A systematic review","volume":"15","author":"Serrano","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S2213-8587(13)70199-2","article-title":"Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: A prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"2","author":"Selvin","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.115.015415","article-title":"Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death","volume":"132","author":"Selvin","year":"2015","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.12669\/pjms.38.8.5579","article-title":"Glycated Albumin and Angiopoietin-2: Possible indicators of Diabetic Retinopathy in Type-Two Diabetes","volume":"38","author":"Ijaz","year":"2022","journal-title":"Pak. J. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jdiacomp.2014.06.015","article-title":"Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study","volume":"28","author":"Pan","year":"2014","journal-title":"J. Diabetes Complicat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"107971","DOI":"10.1016\/j.jdiacomp.2021.107971","article-title":"Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes\u2014A prospective cohort study","volume":"35","author":"Dai","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2337\/dc23-1276","article-title":"Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients with End-Stage Kidney Disease and Burnt-Out Diabetes","volume":"47","author":"Kaminski","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.6065\/apem.2015.20.2.74","article-title":"Alternative biomarkers for assessing glycemic control in diabetes: Fructosamine, glycated albumin, and 1,5-anhydroglucitol","volume":"20","author":"Lee","year":"2015","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ekir.2017.11.009","article-title":"Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients with Diabetes and CKD","volume":"3","author":"Gan","year":"2018","journal-title":"Kidney Int. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Giglio, R.V., Lo Sasso, B., Agnello, L., Bivona, G., Maniscalco, R., Ligi, D., Mannello, F., and Ciaccio, M. (2020). Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113634"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2337\/db13-0782","article-title":"Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT\/EDIC Study","volume":"63","author":"Nathan","year":"2014","journal-title":"Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/jasms.3c00331","article-title":"NanoLC-timsTOF-Assisted Analysis of Glycated Albumin in Diabetes-Affected Plasma and Tears","volume":"35","author":"Tan","year":"2024","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"ref_30","first-page":"12080","article-title":"SALIVA-based diagnostic approach for diabetes mellitus: A step towards non-invasive detection\u2014A scoping review","volume":"27","author":"Cenzato","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"128653","DOI":"10.1155\/2015\/128653","article-title":"\u03b1-2-macroglobulin in saliva is associated with glycemic control in patients with type 2 diabetes mellitus","volume":"2015","author":"Aitken","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Goriuc, A., Cojocaru, K.-A., Luchian, I., Ursu, R.-G., Butnaru, O., and Foia, L. (2024). Using 8-Hydroxy-2\u2032-Deoxiguanosine (8-OHdG) as a Reliable Biomarker for Assessing Periodontal Disease Associated with Diabetes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031425"},{"key":"ref_33","first-page":"e501","article-title":"Salivary gland dysfunction markers in type 2 diabetes mellitus patients","volume":"7","year":"2015","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2100899","DOI":"10.1002\/adma.202100899","article-title":"Energy Autonomous Sweat-Based Wearable Systems","volume":"33","author":"Manjakkal","year":"2021","journal-title":"Adv. Mater."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/866\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:24:07Z","timestamp":1787891047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cimb48090866"],"URL":"https:\/\/doi.org\/10.3390\/cimb48090866","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}